Clinical Study

Pediatric Neurocysticercosis: Usefulness of Antibody Response in Cysticidal Treatment Follow-Up

Table 2

Number of urine samples positive before the treatment and at 3–6 and 12 months after treatment with the use of CSE, ES, and LMM antigens in ELISA (%).

AntigenNCC = 33 (%)
Before RxAfter 3–6 monthsAfter 12 months

CSE20a (60.6)17b (51.5)16c (48.4)
ES18d (54.5)12e (36.3)11f (33.3)
LMM16g (48.4)16h (48.4)15i (45.4)

values a versus b and c; d versus e and f; g versus h and i = >0.05; d versus f = <0.05